Alliance Pharma (GB:APH) has released an update.
Alliance Pharma PLC has reported a notable change in share ownership, with Van Lanschot Kempen Investment Management NV’s voting rights crossing a threshold on June 18, 2024. The investment management firm, based in Amsterdam, now holds 2.779240% of the voting rights in Alliance Pharma, amounting to 15,019,017 shares, which reflects a decrease from their previous notification.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
